These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24023782)

  • 41. Pregnane X-receptor promotes stem cell-mediated colon cancer relapse.
    Planque C; Rajabi F; Grillet F; Finetti P; Bertucci F; Gironella M; Lozano JJ; Beucher B; Giraud J; Garambois V; Vincent C; Brown D; Caillo L; Kantar J; Pelegrin A; Prudhomme M; Ripoche J; Bourgaux JF; Ginestier C; Castells A; Hollande F; Pannequin J; Pascussi JM
    Oncotarget; 2016 Aug; 7(35):56558-56573. PubMed ID: 27448961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer.
    Weissmann-Brenner A; Kushnir M; Lithwick Yanai G; Aharonov R; Gibori H; Purim O; Kundel Y; Morgenstern S; Halperin M; Niv Y; Brenner B
    Int J Oncol; 2012 Jun; 40(6):2097-103. PubMed ID: 22426940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas.
    Li F; Zeng H; Ying K
    Med Oncol; 2011 Dec; 28(4):1458-62. PubMed ID: 20717756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value of early relapse in colon cancer.
    Dai W; Feng Y; Mo S; Xiang W; Li Q; Wang R; Xu Y; Cai G
    Carcinogenesis; 2018 Oct; 39(10):1235-1244. PubMed ID: 29982331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
    Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
    Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A stroma-related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early-stage colon cancer.
    Zhou R; Sun H; Zheng S; Zhang J; Zeng D; Wu J; Huang Z; Rong X; Bin J; Liao Y; Shi M; Liao W
    J Cell Mol Med; 2020 Mar; 24(5):3229-3241. PubMed ID: 31989761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
    Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
    Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse.
    Sinicrope FA; Hart J; Brasitus TA; Michelassi F; Lee JJ; Safa AR
    Cancer; 1994 Dec; 74(11):2908-17. PubMed ID: 7954255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients.
    Lind GE; Guriby M; Ahlquist T; Hussain I; Jeanmougin M; Søreide K; Kørner H; Lothe RA; Nordgård O
    Clin Epigenetics; 2017; 9():97. PubMed ID: 28878843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.
    Yamanaka T; Oki E; Yamazaki K; Yamaguchi K; Muro K; Uetake H; Sato T; Nishina T; Ikeda M; Kato T; Kanazawa A; Kusumoto T; Chao C; Lopatin M; Krishnakumar J; Bailey H; Akagi K; Ochiai A; Ohtsu A; Ohashi Y; Yoshino T
    J Clin Oncol; 2016 Aug; 34(24):2906-13. PubMed ID: 27325854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I-III colon cancer.
    Zhang Z; Feng Q; Jia C; Zheng P; Lv Y; Mao Y; Xu Y; He G; Xu J
    Genomics; 2020 Nov; 112(6):4032-4040. PubMed ID: 32645524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3.
    Miller TJ; McCoy MJ; Hemmings C; Bulsara MK; Iacopetta B; Platell CF
    Pathology; 2017 Dec; 49(7):721-730. PubMed ID: 29102042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer.
    Riera P; Virgili AC; Salazar J; Sebio A; Tobeña M; Sullivan I; Páez D
    Pharmacogenomics J; 2018 Jul; 18(4):556-564. PubMed ID: 29282362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deletion of chromosome 4q predicts outcome in stage II colon cancer patients.
    Brosens RP; Belt EJ; Haan JC; Buffart TE; Carvalho B; Grabsch H; Quirke P; Cuesta MA; Engel AF; Ylstra B; Meijer GA
    Anal Cell Pathol (Amst); 2010; 33(2):95-104. PubMed ID: 20966546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toll-Like Receptor 4 and Matrix Metalloproteases 11 and 13 as Predictors of Tumor Recurrence and Survival in Stage II Colorectal Cancer.
    Eiro N; Carrión JF; Cid S; Andicoechea A; García-Muñiz JL; González LO; Vizoso FJ
    Pathol Oncol Res; 2019 Oct; 25(4):1589-1597. PubMed ID: 30710321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of ERβ and CD44 expression on the prognosis of patients with stage II colon cancer.
    Fang YJ; Zhang L; Wu XJ; Lu ZH; Li JB; Ou QJ; Zhang MF; Ding PR; Pan ZZ; Wan DS
    Tumour Biol; 2012 Dec; 33(6):1907-14. PubMed ID: 22836803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
    Kim YJ; Kim MA; Im SA; Kim TM; Kim DW; Yang HK; Heo DS; Lee KU; Choe KJ; Kim NK; Kim TY; Kim WH; Bang YJ
    Cancer Invest; 2008 Mar; 26(2):152-8. PubMed ID: 18259945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes A and B colon cancer patients undergoing potentially curative surgery.
    Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; Romano C; Vollaro M; Agostini B; Pignatelli C; De Vita F
    Dis Colon Rectum; 2004 Nov; 47(11):1904-14. PubMed ID: 15622584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis.
    Nagata H; Ishihara S; Kishikawa J; Sonoda H; Murono K; Emoto S; Kaneko M; Sasaki K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Kawai K; Nozawa H
    Int J Oncol; 2018 Mar; 52(3):721-732. PubMed ID: 29328371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.